Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors

B Bodaghi, EB Quoc, B Wechsler, THC Tran… - Annals of the …, 2005 - ard.bmj.com
Anti-tumour necrosis factor (TNF) molecules have become a valuable addition to the
therapeutic armamentarium for patients with severe uveitis. 1– 7 A retrospective study was …

[PDF][PDF] Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors.

B Bodaghi, B Wechsler, TH Tran… - Annals of the …, 2005 - europepmc.org
1 Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing
necrotizing scleritis or peripheral ulcerative keratitis; effects of systemic immunosuppression …

[引用][C] Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors

B Bodaghi, EB Quoc, B Wechsler… - Annals of the …, 2005 - pubmed.ncbi.nlm.nih.gov
Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy,
safety, and limiting factors Therapeutic use of infliximab in sight threatening uveitis …

Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors

B Bodaghi, EB Quoc, B Wechsler… - Annals of the …, 2005 - search.proquest.com
immunosuppressive drugs were discontinued and corticosteroids were tapered in four
(33%) cases; methotrexate and low dose corticosteroids were continued in five (42%) cases …

Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors

B Bodaghi, Q Bui, B Wechsler, T Tran… - Annals of the …, 2005 - ncbi.nlm.nih.gov
1 Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing
necrotizing scleritis or peripheral ulcerative keratitis; effects of systemic immunosuppression …

[引用][C] Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors

B BODAGHI, E BUI QUOC… - Annals of the …, 2005 - BMJ Publishing Group